ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

Gene Therapy Appears to Benefit Two Children With ADA Deficiency, Scientist Tells Writers

April 9, 1993

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

Elias Zerhouni Nominated for NIH Director; Richard Carmona For Surgeon General

April 5, 2002

IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes

January 31, 2014

NCAB Subcommittee Worries About Board’s Makeup

January 19, 1979